IL6 and metabolic dysfunction-associated steatotic liver disease: Besides these shared risk factors that link CVD and NAFLD, evidence in NAFLD patients identified many non-traditional and emerging CVD risk factors, including pro-inflammatory cytokines (PCR, IL-6, TNF-α), procoagulant factors (fibrinogen, plasminogen, vascular adhesion molecules), and hyperuricemia [43,44,45].